⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCDA News
BioCardia, Inc. Common Stock
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
globenewswire.com
BCDA
Form 8-K
sec.gov
BCDA
Form 8-K
sec.gov
BCDA
BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026
globenewswire.com
BCDA
Form 8-K
sec.gov
BCDA
BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA
globenewswire.com
BCDA
Form 8-K
sec.gov
BCDA
BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT)
globenewswire.com
BCDA
Stem Cell Therapy Market to Reach USD 45.2B by 2036 (8.4% CAGR) | U.S., Germany & Japan Lead Growth | Mesenchymal Stem Cells Hold 45% Share -- Future Market Insights
prnewswire.com
MESO
GERN
BCDA
NVS
BMY
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart
globenewswire.com
BCDA